Hiroatsu Iida

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.

Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.

Journal: Bone marrow transplantation

Published: May 19, 2026

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Journal: Blood cell therapy

Published: September 01, 2025

Thyroid Storm Following Alemtuzumab-based Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.

Thyroid Storm Following Alemtuzumab-based Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: July 09, 2025

Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.

Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.

Journal: Blood advances

Published: June 30, 2025

Successful treatment of smoldering multiple myeloma-associated type I cryoglobulinemia with bortezomib and autologous peripheral blood stem cell transplantation.

Successful treatment of smoldering multiple myeloma-associated type I cryoglobulinemia with bortezomib and autologous peripheral blood stem cell transplantation.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 01, 2025

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Journal: International journal of hematology

Published: November 18, 2024

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Journal: Journal of hematology

Published: May 26, 2024

A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

Journal: International journal of hematology

Published: May 09, 2024

Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.

Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.

Journal: Hematology reports

Published: December 10, 2023

Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.

Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.

Journal: Clinical pharmacology in drug development

Published: October 12, 2023

The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study.

The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study.

Journal: Pulmonary pharmacology & therapeutics

Published: October 06, 2023

Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia

Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026